Advertisement

International Journal of Clinical Pharmacy

, Volume 36, Issue 1, pp 136–144 | Cite as

Pharmacists’ attitudes and perceived barriers to provision of adherence support in Australia

  • Sarab M. MansoorEmail author
  • Parisa Aslani
  • Ines Krass
Research Article

Abstract

Background Adherence to therapy is a key to achieving good clinical outcomes. Promoting medication adherence requires a range of strategies that primarily focus on fostering behavioral change. Community pharmacists are well placed to deliver adherence support to patients. Aim To investigate community pharmacists’ activities in supporting patient medication adherence in their practice; and to assess pharmacists’ attitudes and barriers to adherence support. Method A sample of 500 pharmacies was randomly selected from a list of community pharmacies in the state of New South Wales (Australia) and mailed a questionnaire focusing on provision of adherence support, pharmacists’ attitudes, and barriers to adherence support. Two follow-up reminders were sent to non-responding pharmacies after 2 and 6 weeks. Result A response rate of 27.6 % was achieved (n = 126), consistent with recent research studies. For less than half (42 %) of prescriptions dispensed, pharmacists reported providing strategies to identify non-adherent patients. Providing dose administration aids was the most common method to support adherence used by pharmacists (95 %). Most (98 %) agreed that it was their role to promote patients’ adherence. However 64 and 52 % reported that patients’ time pressures and poor health literacy, respectively, were the main barriers to provision of adherence support. Around 25 % of respondents reported that they had received training programs on providing medication adherence support. Conclusion Community pharmacists employed a limited range of strategies to identify and address non-adherence to medications. Moreover, the provision of adherence support was episodic and infrequent. However, the majority of pharmacists believed that it is their role to promote patients adherence. Time pressures for both pharmacists and patients were perceived to be a major barrier.

Keywords

Adherence Attitudes Australia Barriers Medications Pharmacists 

Notes

Acknowledgments

The authors are grateful to all participating community pharmacists who completed and returned the questionnaires. We also thank the Faculty of Pharmacy, University of Sydney for their support.

Funding

None.

Conflicts of interest

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. 1.
    Improving adherence in cardiovascular care: a toolkit for health professionals. National Heart Foundation of Australia. 2011. ISBN: 978-1-921748-62-2.Google Scholar
  2. 2.
    Sabate E. Adherence to long-term therapies: evidence for action. World Health Organization. 2003. ISBN: 92-4-15499-2.Google Scholar
  3. 3.
    Reid D, Abramson M, Raven J, Walters HE. Management and treatment perceptions among young adults with asthma in Melbourne: the Australian experience from the European community respiratory health survey. Respirology. 2000;5(3):281–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24.PubMedCrossRefGoogle Scholar
  5. 5.
    Bauman LJ, Wright E, Leickly FE, Crain E, Kruszon-Moran D, Wade SL, et al. Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics. 2002;110(1):6.CrossRefGoogle Scholar
  6. 6.
    Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol. 2001;57(1):77–83.PubMedCrossRefGoogle Scholar
  7. 7.
    Osterberg L, Blaschke T. Adherence to medication. NEJM. 2005;353:487–97.PubMedCrossRefGoogle Scholar
  8. 8.
    Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Baroletti S, Dell’Orfano H. Medication adherence in cardiovascular disease. Circulation. 2010;121(12):1455–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Mansoor SM, Krass I, Aslani P. Multiprofessional interventions to improve patient adherence to cardiovascular medications. J Cardiovasc Pharmacol. 2012;18(1):19–30. doi: 10.1177/1074248412442001.Google Scholar
  11. 11.
    Saini B, Krass I, Smith L, Bosnic-Anticevich S, Armour C. Role of community pharmacists in asthma–Australian research highlighting pathways for future primary care models. Aust Med J. 2011;4(4):190–200.Google Scholar
  12. 12.
    Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409–19.PubMedCrossRefGoogle Scholar
  13. 13.
    Carter BL, Elliott WJ. The role of pharmacists in the detection, management, and control of hypertension: a national call to action. Pharmacotherapy. 2000;20(2):119–22.PubMedCrossRefGoogle Scholar
  14. 14.
    Kristin NLDP, Ashen D. Key strategies to maximize adherence to secondary prevention therapies for coronory artery disease. 2011. Cited 11 Aug 2012. Available from http://www.medscape.org/viewarticle/736196.
  15. 15.
    Carter BL, Zillich AJ, Elliott WJ. How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens. 2003;5(1):31–7.CrossRefGoogle Scholar
  16. 16.
    Rouse MJ. Continuing professional development in pharmacy. J Am Pharm Assoc. 2004;44(4):517–20.CrossRefGoogle Scholar
  17. 17.
    Ho PM, Bryson CL, Rumsfeld JS. Medication adherence. Circulation. 2009;119(23):3028–35.PubMedCrossRefGoogle Scholar
  18. 18.
    Burns K, Turnbull F, Patel A, Peiris D. Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance. Int J Pharm Pract. 2012;20(3):155–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Naing L, Winn T, Rusli B. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci. 2006;1:9–14.Google Scholar
  20. 20.
    Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40(4):475–85.Google Scholar
  21. 21.
    Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(15):S123–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Haynes RB, McDonald H, Garg A, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;2:CD000011.PubMedGoogle Scholar
  23. 23.
    Zyczynski TM, Coyne KS. Hypertension and current issues in compliance and patient outcomes. Curr Hypertens Rep. 2000;2(6):510–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: development and validation of the “Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire”. Patient Educ Couns. 2007;64(1):151–8.Google Scholar
  25. 25.
    Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc. 2000;40(6):773–9.Google Scholar
  26. 26.
    Lackey NR, Sullivan JJ, Pett MA. Making sense of factor analysis: the use of factor analysis for instrument development in health care research. California: Sage Publications Inc; 2003. ISBN: 978-0761919506.Google Scholar
  27. 27.
    Australian Institute of Health and Welfare 2009. Canberra: Australia`s Welfare 2009. AIWH Cat. No. AUS 117 Series no. 9; 2009. ISBN: 978-1-74024-956-0.Google Scholar
  28. 28.
    Guild Digest. A survey of independent pharmacy operations in Australia financial year 2009–10. Australia: The Pharmacy Guild of Australia; November 2011. ISSN: 1328-1895.Google Scholar
  29. 29.
    Guy M, Boesen K. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists. J Am Pharm Assoc. 2009;49:26–30.CrossRefGoogle Scholar
  30. 30.
    Possidente CJ, Anzisi L, Algozzine TW, Buckley TE, Weathermon R. Pharmacists’ activities supporting medication adherence: a regional survey. J Am Pharm Assoc. 2005;45(6):743–5.CrossRefGoogle Scholar
  31. 31.
    Benrimoj SI, Frommer MS. Community pharmacy in Australia. Aust Health Rev. 2004;28(2):238–46.PubMedCrossRefGoogle Scholar
  32. 32.
    Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42(6):861–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Peterson-Clark G, Aslani P, Williams KA. Pharmacists’ online information literacy: an assessment of their use of Internet based medicines information. Health Info Libr J. 2010;27(3):208–16.PubMedCrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2013

Authors and Affiliations

  1. 1.Faculty of PharmacyThe University of SydneySydneyAustralia

Personalised recommendations